Connor, Clark & Lunn Investment Management (CC&L)’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $177K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $337K | Hold |
|
|||||
|
2019
Q3 | $481K | Sell |
|
|||||
|
2019
Q2 | $943K | Sell |
|
|||||
|
2019
Q1 | $1.12M | Sell |
|
|||||
|
2018
Q4 | $653K | Sell |
|
|||||
|
2018
Q3 | $914K | Sell |
|
|||||
|
2018
Q2 | $858K | Buy |
|
|||||
|
2018
Q1 | $1.15M | Buy |
|
|||||
|
2017
Q4 | $909K | Buy |
|
|||||
|
2017
Q3 | $520K | Buy |
|
|||||
|
2017
Q2 | $99K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $589K | Sell |
|
|||||
|
2016
Q1 | $4.1M | Sell |
|
|||||
|
2015
Q4 | $6.92M | Sell |
|
|||||
|
2015
Q3 | $8.64M | Sell |
|
|||||
|
2015
Q2 | $12.7M | Sell |
|
|||||
|
2015
Q1 | $12.5M | Buy |
|
|||||
|
2014
Q4 | $8.36M | Buy |
|
|||||
|
2014
Q3 | $1.38M | Buy |
|